Stockscreener 앱 받기
12.75
13.26%
-1.9499
시장 영업 전:
14.50
1.7499
+13.72%
Eloxx Pharmaceuticals Inc 주식(ELOX)의 최신 뉴스
Invus-led group holds 9.99% of Eloxx (ELOX) via shares and warrants - Stock Titan
ELOX Technical Analysis & ETF Price Forecast - Intellectia AI
symbol__ Stock Quote Price and Forecast - CNN
ELOX Price Today: Eloxx Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Eloxx Pharma (ELOX) Stock Analysis Report | Financials & Insights - Benzinga
Eloxx (NASDAQ: ELOX) CEO receives 328,833 performance-based stock options - Stock Titan
Eloxx Pharmaceuticals (ELOX) director receives 13,587 stock options grant - Stock Titan
Eloxx (ELOX) director Steven Rubin receives 4,018 stock options at $11 strike - Stock Titan
Eloxx (ELOX) director Stephen Webster receives stock options for 13,587 shares - Stock Titan
ELOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ELOX Technical Analysis & Stock Price Forecast - Intellectia AI
ELOX PE Ratio & Valuation, Is ELOX Overvalued - Intellectia AI
ELOX News & Events - Intellectia AI
ELOX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Eloxx Pharmaceuticals, Inc.(NasdaqCM: ELOX) added to NASDAQ Composite Index - marketscreener.com
Form 424B4 Eloxx Pharmaceuticals, - StreetInsider
Eloxx Pharmaceuticals (ELOX) raises ~$66M via stock and pre‑funded warrants - Stock Titan
Eloxx Pharmaceuticals Offering Expected to Close June 10 >ELOX - Moomoo
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering - Pharmaceutical Executive
[EFFECT] Eloxx Pharmaceuticals, Inc. SEC Filing - Stock Titan
Eloxx Pharmaceuticals prices $66.0 million offering, uplists to Nasdaq - scanx.trade
Eloxx Pharmaceuticals: Shares Expected to Start Trading on Nasdaq Capital Market on June 9 >ELOX - Moomoo
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire
Eloxx Pharmaceuticals Inc (ELOXD) Stock PDF (Updated: 2026/06/06) - GuruFocus
ELOX SEC FilingsEloxx Pharmaceut 10-K, 10-Q, 8-K Forms - Stock Titan
Domicilium files Schedule 13G/A reporting 4.9% stake in Eloxx (NASDAQ: ELOX) - Stock Titan
Domicilium Real Estate Fund III LP (ELOX) swaps 1.25M shares for pre-funded warrants - Stock Titan
Total debt per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Working capital per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Book value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on invested capital % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Free cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net current asset value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Asset turnover of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Operating cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
CapEx per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on assets % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Price to cash flow ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBIT per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Enterprise value of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals, Inc. Statistics – OTC:ELOXD - TradingView
Enterprise value to EBITDA ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total liabilities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total debt of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Free float of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Basic earnings per share (basic EPS) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Non-operating income (total) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBIT of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Non-controlling/minority interest of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Cash from financing activities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Pretax income of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Cash from investing activities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net income before discontinued operations of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Diluted net income available to common stockholders of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Operating expenses (excl. COGS) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Operating income of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals, Inc. Cash Flow – OTC:ELOXD - TradingView
Dilution adjustment of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Taxes of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total operating expenses of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Total revenue of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Gross profit of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Preferred dividends of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Average basic shares outstanding of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
After tax other income/expense of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Diluted earnings per share (diluted EPS) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
1.27%
1.43%
자본화:
|
볼륨(24시간):